Unichem Laboratories share price
You have to be logged in to add this to Watchlist.- ₹467.80(-0.29%)November 14, 2025 15:19:35 PM IST
- NSE
- BSE
- Vol : 31.98K (NSE + BSE)Last 20 day avg : 26.64 K
Unichem Laboratories is trading -0.29% lower at Rs 467.80 as compared to its last closing price. Unichem Laboratories has been trading in the price range of 478.80 & 461.00. Unichem Laboratories has given -36.86% in this year & -0.10% in the last 5 days. Unichem Laboratories has TTM P/E ratio 31.70 as compared to the sector P/E of 30.99.The company posted a net profit of -10.47 Crores in its last quarter.Listed peers of Unichem Laboratories include Unichem Laboratories (-0.29%), Neuland Laboratories (0.44%), Jagsonpal Pharmaceuticals (0.05%).The Mutual Fund holding in Unichem Laboratories was at 9.17% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Unichem Laboratories was at 0.99% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 14, 2025, 06:49 PM UTC
- BetaLow volatility0.42Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.19The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.35The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values25.35Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.42The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable
The company's revenue grew in June quarter by 17.96% from Rs 526.60 crore to Rs 446.43 crore, year-on-year- Company has registered a loss of 10.47 cr vs a profit of 9.26 cr in the same quarter last year.
- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 498.50
- R2
- 522.55
- R3
- 552.55
- S1
- 444.45
- S2
- 414.45
- S3
- 390.40
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Unichem Laboratories | Bearish | 467.80 | -0.29 | 3,300.27 | 32.60 | 1.81 | - | 3.51 |
| Neuland Laboratories | Bullish | 17,300.10 | 0.44 | 22,112.97 | 89.36 | 12.2 | 0.08 | 7.17 |
| Jagsonpal Pharmaceuticals | Bearish | 210.00 | 0.05 | 1,401.22 | 42.76 | 6.99 | 0.79 | 3.18 |
| Astrazeneca Pharma India | Neutral | 9,133.00 | -0.77 | 22,870.02 | 125.32 | 30.49 | 0.34 | 3.82 |
| Themis Medicare | Bearish | 116.90 | -1.47 | 1,071.89 | 39.13 | 2.9 | 0.39 | 4.62 |
- Promoter(s) holds a high stake in the company at 70.22%
- FIIs are invested in this company
- FIIs holding has increased by 0.01 percentage points from previous quarter
- Mutual Funds holding has decreased by 0.22 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-22 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
- IndustryMajor Drugs
- ISININE351A01035
- BSE Code506690
- NSE CodeUNICHEMLAB
Unichem Laboratories is trading at 467.80 as on Fri Nov 14 2025 09:49:35. This is -0.29% lower as compared to its previous closing price of 469.15.
The market capitalization of Unichem Laboratories is 3300.27 Cr as on Fri Nov 14 2025 09:49:35.
The 52 wk high for Unichem Laboratories is 949.85 whereas the 52 wk low is 438.50
Unichem Laboratories can be analyzed on the following key metrics -
- TTM P/E: 31.70
- Sector P/E: 30.99
- Dividend Yield: 0.00%
- D/E ratio: -
Unichem Laboratories reported a net profit of 137.52 Cr in 2025.
The Mutual Fund Shareholding was 9.17% at the end of 30 Sep 2025.